Impact BioMedical

Yahoo Finance • 6 days ago

Omnicell, Inc. (OMCL): A Bull Case Theory

We came across a bullish thesis on Omnicell, Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on OMCL. Omnicell, Inc.'s share was trading at $38.61 as of February 18th. OMCL’s trailing P/E was 9... Full story

Yahoo Finance • 7 months ago

Impact Biomedical announces 3F US patent issue

* Impact Biomedical (NYSE:IBO [https://seekingalpha.com/symbol/IBO]) announced on Monday that the US Patent and Trademark Office has issued a patent titled “Composition and Method of Controlling Infectious Diseases with Functional Fragra... Full story